Cannabinoids, opioids and eating behavior: The molecular face of hedonism?

Positional cloning of the mouse obese gene and its human homologue

Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · see citing works

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Weight-Reducing Effects of the Plasma Protein Encoded by the <i>obese</i> Gene

Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451 · see citing works

Ghrelin induces adiposity in rodents

Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949 · see citing works

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice

Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,612 · see citing works

Identification and expression cloning of a leptin receptor, OB-R.

Tartaglia, L. A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G. J., Campfield, L. A., Clark, F. T., Deeds, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90151-5 · Cited by 3,496 · see citing works

Targeted disruption of the melanocortin-4 receptor results in obesity in mice

Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819 · see citing works

Role of Brain Insulin Receptor in Control of Body Weight and Reproduction

Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235 · see citing works

Obesity and the Environment: Where Do We Go from Here?

Hill, J. O., Wyatt, H. R., Reed, G. W., & Peters, J. C. (2003) · Science · doi:10.1126/science.1079857 · Cited by 2,180 · see citing works

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · see citing works

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · see citing works

Food reward: brain substrates of wanting and liking

Berridge, K. C. (1996) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/0149-7634(95)00033-b · Cited by 1,901 · see citing works

Brain dopamine and obesity

Wang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864 · see citing works

Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor

Reinscheid, R. K., Nothacker, H., Bourson, A., Ardati, A., Henningsen, R. A., Bunzow, J. R., Grandy, D. K., Langen, H., Monsma, F. J., & Civelli, O. (1995) · Science · doi:10.1126/science.270.5237.792 · Cited by 1,824 · see citing works

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,751 · see citing works

The Distribution and Mechanism of Action of Ghrelin in the CNS Demonstrates a Novel Hypothalamic Circuit Regulating Energy Homeostasis

Cowley, M. A., Smith, R. G., Diano, S., Tschöp, M., Pronchuk, N., Grove, K. L., Strasburger, C. J., Bidlingmaier, M., Esterman, M., Heiman, M. L., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00063-1 · Cited by 1,679 · see citing works

Role of Endogenous Cannabinoids in Synaptic Signaling

Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,567 · see citing works

Leptin-regulated endocannabinoids are involved in maintaining food intake

Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559 · see citing works

Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight

Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horváth, T. L., & Kalra, P. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.1.0357 · Cited by 1,556 · see citing works

Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight

Kalra, S. P. (1999) · Endocrine Reviews · doi:10.1210/er.20.1.68 · Cited by 1,554 · see citing works

Identification of targets of leptin action in rat hypothalamus.

Schwartz, M. W., Seeley, R. J., Campfield, L. A., Burn, P., & Baskin, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118891 · Cited by 1,475 · see citing works

A potent and selective endogenous agonist for the µ-opiate receptor

Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,309 · see citing works

Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications

Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,297 · see citing works

Modulation of anxiety through blockade of anandamide hydrolysis

Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · see citing works

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

Cota, D., Marsicano, G., Tschöp, M. H., Grübler, Y., Flachskamm, C., Schubert, M. I., Auer, D. P., Yassouridis, A., Thöne‐Reineke, C., Ortmann, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17725 · Cited by 1,168 · see citing works

The Need to Feed

Saper, C. B., Chou, T. C., & Elmquist, J. K. (2002) · Neuron · doi:10.1016/s0896-6273(02)00969-8 · Cited by 1,120 · see citing works

Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons

Woods, S. C., Lotter, E. C., McKay, L. D., & Porte, D. (1979) · Nature · doi:10.1038/282503a0 · Cited by 1,114 · see citing works

Obesity Wars

Flier, J. S. (2004) · Cell · doi:10.1016/s0092-8674(03)01081-x · Cited by 1,105 · see citing works

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Osei‐Hyiaman, D., DePetrillo, M. A., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J. D., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23057 · Cited by 1,103 · see citing works

How can drug addiction help us understand obesity?

Volkow, N. D., & Wise, R. A. (2005) · Nature Neuroscience · doi:10.1038/nn1452 · Cited by 1,089 · see citing works

The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.

Kieffer, B. L., Befort, K., Gavériaux‐Ruff, C., & HIRTH, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 994 · see citing works

The dopamine hypothesis of reward: past and current status

Spanagel, R., & Weiss, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01447-2 · Cited by 967 · see citing works

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

Huang, S. M., Bisogno, T., Trevisani, M., Al‐Hayani, A., PETROCELLIS, L. D., Fezza, F., Tognetto, M., Petros, T. J., Krey, J. F., Chu, C. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122196999 · Cited by 962 · see citing works

Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning

Kelley, A. E. (2004) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.11.015 · Cited by 942 · see citing works

Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain

Marsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937 · see citing works

Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition

Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813 · see citing works

Nongenomic Glucocorticoid Inhibition via Endocannabinoid Release in the Hypothalamus: A Fast Feedback Mechanism

Di, S., Malcher‐Lopes, R., Halmos, K. C., & Tasker, J. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04850.2003 · Cited by 801 · see citing works

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

Kirkham, T. C., Williams, C. M., Fezza, F., & Marzo, V. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704767 · Cited by 788 · see citing works

2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor

Hanuš, L., Abu‐Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I. M., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 761 · see citing works

Endocannabinoid control of food intake and energy balance

Marzo, V. D., & Matias, I. (2005) · Nature Neuroscience · doi:10.1038/nn1457 · Cited by 746 · see citing works

Opioid receptors

Waldhoer, M., Bartlett, S. E., & Whistler, J. L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073940 · Cited by 740 · see citing works

Multiple neural systems controlling food intake and body weight

Berthoud, H.-R. (2002) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00014-3 · Cited by 725 · see citing works

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action

Marzo, V. D., Melck, D. J., Bisogno, T., & PETROCELLIS, L. D. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 704 · see citing works

Modulation of transmitter release via presynaptic cannabinoid receptors

Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671 · see citing works

Opiate receptor: autoradiographic localization in rat brain.

Pert, C. B., Kuhar, M. J., & Snyder, S. H. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.10.3729 · Cited by 630 · see citing works

Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor

Porter, A. C., Sauer, J., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J., Nomikos, G. G., Carter, P. A., Bymaster, F. P., Leese, A. B., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1020 · Cited by 614 · see citing works

Cortical and limbic activation during viewing of high- versus low-calorie foods

Killgore, W. D. S., Young, A. D., Femia, L. A., Bogorodzki, P., Rogowska, J., & Yurgelun-Todd, D. A. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00191-5 · Cited by 581 · see citing works

Minireview: Ghrelin and the Regulation of Energy Balance--A Hypothalamic Perspective

Horváth, T. L., Diano, S., Sótonyi, P., Heiman, M. L., & Tschöp, M. H. (2001) · Endocrinology · doi:10.1210/endo.142.10.8490 · Cited by 570 · see citing works

Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain

Breivogel, C. S., Griffin, G., Marzo, V. D., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 540 · see citing works

Opioid modulation of taste hedonics within the ventral striatum

Kelley, A. E., Bakshi, V. P., Haber, S. N., Steininger, T. L., Will, M. J., & Zhang, M. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00751-5 · Cited by 526 · see citing works

Melanocortin receptors in leptin effects

Seeley, R. J., Yagaloff, K. A., Fisher, S. L., Burn, P., Thiele, T. E., van Dijk, G., Baskin, D. G., & Schwartz, M. W. (1997) · Nature · doi:10.1038/37016 · Cited by 522 · see citing works

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

Williams, C. M., & Kirkham, F. J. (1999) · Psychopharmacology · doi:10.1007/s002130050953 · Cited by 508 · see citing works

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

Storkebaum, E., Lambrechts, D., Dewerchin, M. A., Moreno-Murciano, P., Appelmans, S., Oh, H., Damme, P. V., Rutten, B. P. F., Man, W. Y., Mol, M. D., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1360 · Cited by 495 · see citing works

Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain

Colantuoni, C., Schwenker, J., McCarthy, J., Rada, P., Ladenheim, B., Cadet, J.-L., Schwartz, G. J., Moran, T. H., & Hoebel, B. G. (2001) · Neuroreport · doi:10.1097/00001756-200111160-00035 · Cited by 471 · see citing works

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

Jamshidi, N., & Taylor, D. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704379 · Cited by 466 · see citing works

Orexin (Hypocretin) Neurons Contain Dynorphin

Chou, T. C., Lee, C. E., Lü, J., Elmquist, J. K., Hara, J., Willie, J. T., Beuckmann, C. T., Chemelli, R. M., Sakurai, T., Yanagisawa, M., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-j0003.2001 · Cited by 430 · see citing works

Taste, olfactory, and food texture processing in the brain, and the control of food intake

Rolls, E. T. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.04.012 · Cited by 429 · see citing works

Serotonergic control of the organization of feeding and satiety

Simansky, K. J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00066-6 · Cited by 427 · see citing works

Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus

Hájos, N., Ledent, C. A., & Freund, T. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00287-1 · Cited by 420 · see citing works

SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Cohen, C., Perrault, G., Voltz, C., Steinberg, R., & Soubrié, P. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00018 · Cited by 396 · see citing works

The Neuroanatomical Axis for Control of Energy Balance

Grill, H. J., & Kaplan, J. M. (2002) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0224 · Cited by 395 · see citing works

Pharmacological and biochemical interactions between opioids and cannabinoids

Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 391 · see citing works

Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor

Meunier, J.-C. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01411-8 · Cited by 389 · see citing works

Endocannabinoid signaling system and brain reward: emphasis on dopamine

GARDNER, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.032 · Cited by 387 · see citing works

N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo

Bisogno, T., Melck, D. J., BOBROV, M. Y., Gretskaya, N. M., Безуглов, В. В., PETROCELLIS, L. D., & Marzo, V. D. (2000) · Biochemical Journal · doi:10.1042/bj3510817 · Cited by 382 · see citing works

Expression of the melanin‐concentrating hormone (MCH) receptor mRNA in the rat brain

Saito, Y., Cheng, M., Leslie, F. M., & Civelli, O. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1191 · Cited by 381 · see citing works

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Navarro, M., Carrera, M. R. A., Fratta, W., Valverde, O., Cossu, G., Fattore, L., Chowen, J. A., Gómez, R., del Arco, I., Villanúa, M. A., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05344.2001 · Cited by 378 · see citing works

Sensitivity to reward: implications for overeating and overweight

Davis, C. A., Strachan, S. M., & Berkson, M. (2003) · Appetite · doi:10.1016/j.appet.2003.07.004 · Cited by 378 · see citing works

Synthesis and Characterization of Potent and Selective Agonists of the Neuronal Cannabinoid Receptor (CB1)

Hillard, C. J., Manna, S., Greenberg, M. J., DiCamelli, R. F., Ross, R. A., Stevenson, L., Murphy, V. L., Pertwee, R. G., & Campbell, W. B. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38289-8 · Cited by 373 · see citing works

Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor

Sugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H., & Waku, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.605 · Cited by 370 · see citing works

A missense mutation in human fatty acid amide hydrolase associated with problem drug use

Sipe, J. C., Chiang, K. P., Gerber, A. L., Beutler, E., & Cravatt, B. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082235799 · Cited by 354 · see citing works

Dopamine Production in the Caudate Putamen Restores Feeding in Dopamine-Deficient Mice

Szczypka, M. S., Kwok, K., Brot, M. D., Marck, B. T., Matsumoto, A. M., Donahue, B. A., & Palmiter, R. D. (2001) · Neuron · doi:10.1016/s0896-6273(01)00319-1 · Cited by 354 · see citing works

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance

Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0356 · Cited by 346 · see citing works

Intake of High-Fat Food Is Selectively Enhanced by Mu Opioid Receptor Stimulation within the Nucleus Accumbens

Zhang, M., Gosnell, B. A., & Kelley, A. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37432-4 · Cited by 332 · see citing works

Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity

Lichtman, A. H., Leung, D., Shelton, C. C., Saghatelian, A., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069401 · Cited by 329 · see citing works

Opioid peptides and the control of human ingestive behaviour

Yeomans, M. R., & Gray, R. W. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00041-6 · Cited by 317 · see citing works

Endogenous cannabinoid system as a modulator of food intake

Cota, D., Marsicano, G., Lutz, B., Vicennati, V., Stalla, G. K., Pasquali, R., & Pagotto, U. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802250 · Cited by 313 · see citing works

Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological Function

Bisogno, T., Berrendero, F., Ambrosino, G., Cebeira, M., Ramos, J. A., Fernández‐Ruíz, J., & Marzo, V. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0254 · Cited by 313 · see citing works

Gastrointestinal Satiety Signals I. An overview of gastrointestinal signals that influence food intake

Woods, S. C. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00448.2003 · Cited by 311 · see citing works

Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor

Sugiura, T., Kodaka, T., Nakane, S., Miyashita, T., Kondo, S., Suhara, Y., Takayama, H., Waku, K., Seki, C., Baba, N., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2794 · Cited by 311 · see citing works

‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance

Marzo, V. D. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00042-3 · Cited by 310 · see citing works

Stimulation of Endorphin Neurotransmission in the Nucleus Accumbens by Ethanol, Cocaine, and Amphetamine

Olive, M. F., Koenig, H. N., Nannini, M., & Hodge, C. W. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-j0002.2001 · Cited by 300 · see citing works

Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain

Hermann, H., Marsicano, G., & Lutz, B. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00509-7 · Cited by 290 · see citing works

Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence

Foll, B. L., & Goldberg, S. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 290 · see citing works

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms?a review of recent preclinical data

Tanda, G., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1485-z · Cited by 280 · see citing works

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

González, S. R., Cascio, M. G., Fernández‐Ruíz, J., Fezza, F., Marzo, V. D., & Ramos, J. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03344-9 · Cited by 278 · see citing works

Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study

Volkow, N. D., Wang, G., Fowler, J. S., Thanos, P., Logan, J., Gatley, S. J., Gifford, A. J., Ding, Y., Wong, C., & Pappas, N. R. (2002) · Synapse · doi:10.1002/syn.10137 · Cited by 275 · see citing works

Blood Levels of the Endocannabinoid Anandamide are Increased in Anorexia Nervosa and in Binge-Eating Disorder, but not in Bulimia Nervosa

Monteleone, P., Matias, I., Martiadis, V., PETROCELLIS, L. D., Maj, M., & Marzo, V. D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300695 · Cited by 272 · see citing works

Hyperphagia in pre-fed rats following oral δ9-THC

Williams, C. M., Rogers, P. J., & Kirkham, T. C. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00170-x · Cited by 258 · see citing works

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)

Sipe, J. C., Waalen, J., Gerber, A., & Beutler, E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802954 · Cited by 257 · see citing works

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors

Gatley, S. J., Gifford, A. N., Volkow, N. D., Lan, R., & Makriyannis, A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00279-8 · Cited by 252 · see citing works

Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N -acylethanolamines in piglets

Berger, A., Crozier, G. L., Bisogno, T., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101119098 · Cited by 247 · see citing works

Clinical Trials Update and Cumulative Meta-Analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and Cardiac Resynchronisation Therapy in Heart Failure

Cleland, J. G. F., GHOSH, J. M., Freemantle, N., Kaye, G., Nasir, M., Clark, A. L., & Coletta, A. P. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.04.014 · Cited by 244 · see citing works

Feeding behavior in dopamine-deficient mice

Szczypka, M. S., Rainey, M. A., Kim, D. S., Alaynick, W. A., Marck, B. T., Matsumoto, A. M., & Palmiter, R. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12138 · Cited by 242 · see citing works

Anandamide receptors

Marzo, V. D., PETROCELLIS, L. D., Fezza, F., Ligresti, A., & Bisogno, T. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0349 · Cited by 238 · see citing works

Brain dopamine is associated with eating behaviors in humans

Volkow, N. D., Wang, G., Maynard, L., Jayne, M., Fowler, J. S., Zhu, W., Logan, J., Gatley, S. J., Ding, Y., Wong, C., et al. (2003) · International Journal of Eating Disorders · doi:10.1002/eat.10118 · Cited by 235 · see citing works

Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist

Gallate, J. E., Saharov, T., Mallet, P. E., & McGregor, I. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00170-3 · Cited by 235 · see citing works

The direct and indirect controls of meal size

Smith, G. P. (1996) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/0149-7634(95)00038-g · Cited by 234 · see citing works

Monitoring of stored and available fuel by the CNS: implications for obesity

Seeley, R. J., & Woods, S. C. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1245 · Cited by 228 · see citing works

The endocannabinoid nervous system

Porter, A. C., & Felder, C. C. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00130-9 · Cited by 226 · see citing works

Cannabinoid CB1 receptors control conditioned drug seeking

Vries, T. J. D., & Schoffelmeer, A. N. M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.06.002 · Cited by 219 · see citing works

Minireview: Nutrient Sensing and the Regulation of Insulin Action and Energy Balance

Obici, S., & Rossetti, L. (2003) · Endocrinology · doi:10.1210/en.2003-0999 · Cited by 218 · see citing works

Minireview: Human Obesity—Lessons from Monogenic Disorders

O’Rahilly, S., Farooqi, I. S., Yeo, G. S. H., & Challis, B. (2003) · Endocrinology · doi:10.1210/en.2003-0373 · Cited by 218 · see citing works

Regulation of Opioid Receptor Activities

Law, P., & Loh, H. H. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38179-0 · Cited by 206 · see citing works

The eating disorders as addiction

Davis, C. A., & CLARIDGE, G. S. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00009-4 · Cited by 205 · see citing works

The endocannabinoid signalling system: Biochemical aspects

Bisogno, T., Ligresti, A., & Marzo, V. D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.027 · Cited by 200 · see citing works

Prolonged effect of an anesthetic dose of ketamine on behavioral despair

Yılmaz, A., Schulz, D., Aksoy‐Aksel, A., & Canbeyli, R. S. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00693-1 · Cited by 199 · see citing works

Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor

Hilairet, S., Bouaboula, M., Carrière, D., Fur, G. L., & Casellas, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212369200 · Cited by 188 · see citing works

Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens

Zhang, M., & Kelley, A. E. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0932-y · Cited by 186 · see citing works

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

Poncelet, M., Maruani, J., Calassi, R., et al. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00397-5 · Cited by 162 · see citing works

Eating Elicited by Orexin-A, But Not Melanin-Concentrating Hormone, Is Opioid Mediated

Clegg, D. J., Air, E. L., Woods, S. C., & Seeley, R. J. (2002) · Endocrinology · doi:10.1210/endo.143.8.8977 · Cited by 160 · see citing works

Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine

Williams, C. M., & Kirkham, T. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00694-3 · Cited by 158 · see citing works

Synergistic efects of opioid and cannabinoid antagonists on food intake

Kirkham, T. C., & Williams, C. M. (2001) · Psychopharmacology · doi:10.1007/s002130000596 · Cited by 156 · see citing works

Cannabis: Effects on hunger and thirst

Abel, E. L. (1975) · Behavioral Biology · doi:10.1016/s0091-6773(75)91684-3 · Cited by 155 · see citing works

Endogenous cannabinoids and appetite

Kirkham, T. C., & Williams, C. M. (2001) · Nutrition Research Reviews · doi:10.1079/095442201108729141 · Cited by 152 · see citing works

Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake

Stratford, T. R., Holahan, M. R., & Kelley, A. E. (1997) · Neuroreport · doi:10.1097/00001756-199701200-00009 · Cited by 151 · see citing works

Flavor enhances the antidipsogenic effect of naloxone

Levine, A. S., Murray, S. S., Kneip, J. M., et al. (1982) · Physiology & Behavior · doi:10.1016/0031-9384(82)90095-6 · Cited by 151 · see citing works

Palatability-induced hyperphagia increases hypothalamic Dynorphin peptide and mRNA levels

Welch, C. C., Kim, E., Grace, M. K., Billington, C. J., & Levine, A. S. (1996) · Brain Research · doi:10.1016/0006-8993(96)00151-5 · Cited by 146 · see citing works

Opioid and anti‐opioid peptides

Cesselin, F. (1995) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1995.tb00517.x · Cited by 142 · see citing works

Morphine- and naltrexone-induced modification of palatability: Analysis by the taste reactivity test.

Parker, L. A., Maier, S., Rennie, M., & Crebolder, J. (1992) · Behavioral Neuroscience · doi:10.1037//0735-7044.106.6.999 · Cited by 142 · see citing works

Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats

Rowland, N. E., Mukherjee, M., & Robertson, K. (2001) · Psychopharmacology · doi:10.1007/s002130100910 · Cited by 139 · see citing works

Opioids as agents of reward-related feeding: a consideration of the evidence

Levine, A. S., & Billington, C. J. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.04.032 · Cited by 138 · see citing works

Endogenous cannabinoids and appetite.

Kirkham, F. J., & Williams, C. M. (2001) · PubMed · doi:10.1079/nrr200118 · Cited by 133 · see citing works

Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?

Harrold, J. A., Elliott, J. C., King, P., Widdowson, P. S., & Williams, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03245-6 · Cited by 130 · see citing works

Morphine- and naltrexone-induced modification of palatability: Analysis by the taste reactivity test.

Parker, L. A., Maier, S., Rennie, M., et al. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.6.999 · Cited by 126 · see citing works

Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues

Fezza, F., Bisogno, T., Minassi, A., et al. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02341-4 · Cited by 125 · see citing works

Opiate blockade inhibits saccharin intake and blocks normal preference acquisition

Lynch, W. C. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90420-x · Cited by 118 · see citing works

Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine

Vela, G., Ruiz-gayo, M., & Fuentes, J. A. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00032-2 · Cited by 118 · see citing works

Food Cravings, Endogenous Opioid Peptides, and Food Intake: A Review

Mercer, M. E., & Holder, M. D. (1997) · Appetite · doi:10.1006/appe.1997.0100 · Cited by 116 · see citing works

Binding of anandamide to bovine serum albumin

Bojesen, I. N., & Hansen, H. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300170-jlr200 · Cited by 115 · see citing works

Endocannabinoid system and alcohol addiction: Pharmacological studies

Colombo, G., SERRA, S., VACCA, G., Carai, M. A. M., & GESSA, G. L. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.022 · Cited by 114 · see citing works

Cannabinoid Withdrawal Syndrome Is Reduced in Pre-Proenkephalin Knock-Out Mice

Valverde, O., Maldonado, R. J., Valjent, E., Zimmer, A. M., & Zimmer, A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09284.2000 · Cited by 110 · see citing works

Association of anorexia nervosa with the high activity allele of the COMT gene: a family-based study in Israeli patients

Frisch, A., Laufer, N., Danziger, Y., Michaelovsky, E., Leor, S., Carel, C. A., Stein, D. J., Fennig, S., Mimouni, M., Apter, A. S., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000830 · Cited by 107 · see citing works

Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice

Yamaguchi, T., Hagiwara, Y., Tanaka, H., Sugiura, T., Waku, K., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02655-5 · Cited by 104 · see citing works

The floating blueprint of hypothalamic feeding circuits

Horváth, T. L., & Diano, S. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1479 · Cited by 102 · see citing works

Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A

Vries, T. J. D., de Vries, W., Janssen, M. C. W., & Schoffelmeer, A. N. M. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.02.021 · Cited by 102 · see citing works

Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy

Glass, M. J., Billington, C. J., & Levine, A. S. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.1.r86 · Cited by 101 · see citing works

Dual Action of Naloxone on Feeding Revealed by Behavioural Analysis: Separate Effects on Initiation and Termination of Eating

Kirkham, T. C., & Blundell, J. E. (1984) · Appetite · doi:10.1016/s0195-6663(84)80049-5 · Cited by 100 · see citing works

Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: Differences between restricting and bingeing/purging subtypes

Siegfried, Z., Kanyas, K., Latzer, Y., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20089 · Cited by 100 · see citing works

Nalmefene: Intravenous safety and kinetics of a new opioid antagonist

Dixon, R., Howes, J. F., Gentile, J., Hsu, H., Hsiao, J. H., Garg, D. C., Weidler, D. J., Meyer, M. C., & Tuttle, R. R. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.9 · Cited by 98 · see citing works

Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine

Viganò, D., Valenti, M., Cascio, M. G., Marzo, V. D., Parolaro, D., & Rubino, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03645.x · Cited by 97 · see citing works

Ether‐linked analogue of 2‐arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species

Oka, S., Tsuchie, A., Tokumura, A., Muramatsu, M., Suhara, Y., Takayama, H., Waku, K., & Sugiura, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01804.x · Cited by 96 · see citing works

Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl Glycerol, in Rat Brain

Viganò, D., Cascio, M. G., Rubino, T., Fezza, F., Vaccani, A., Marzo, V. D., & Parolaro, D. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300117 · Cited by 95 · see citing works

Morphine and opioid peptides reduce paraventricular neuronal activity: studies on the rat hypothalamic slice preparation.

Pittman, Q. J., Hatton, J. D., & Bloom, F. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5527 · Cited by 94 · see citing works

Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action.

Kotz, C. M., Grace, M. K., Briggs, J., Levine, A., & Billington, C. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118017 · Cited by 90 · see citing works

Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand

Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 90 · see citing works

Δ-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat

Corchero, J., Avila, M. A., Fuentes, J. A., & Manzanares, J. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00405-0 · Cited by 86 · see citing works

Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids

Beinfeld, M. C., & Connolly, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01591-9 · Cited by 86 · see citing works

Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels

de Lago, E., Petrosino, S., Valenti, M., Morera, E., Ortega‐Gutiérrez, S., Fernández‐Ruíz, J., & Marzo, V. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.011 · Cited by 85 · see citing works

Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens

MacDonald, A. F., Billington, C. J., & Levine, A. S. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.043 · Cited by 83 · see citing works

Deletion of CCK2Receptor in Mice Results in an Upregulation of the Endogenous Opioid System

Pommier, B., Beslot, F., Simon, A., Pophillat, M., Matsui, T., Daugé, V., Roques, B. P., & Noble, F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-02005.2002 · Cited by 82 · see citing works

Opioid mediation of odor preferences induced by sugar and fat in 6-day-old rats

Shide, D. J., & Blass, E. M. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90422-k · Cited by 81 · see citing works

Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-βγ dimers

Yao, L., Fan, P., Jiang, Z., Mailliard, W. S., Gordon, A. S., & Diamond, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336093100 · Cited by 81 · see citing works

Cholecystokinin/opioid interactions

Wiesenfeld‐Hallin, Z., Lucas, G. D. A., Alster, P., Xu, X., & Hökfelt, T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01978-2 · Cited by 80 · see citing works

Endocannabinoids and the regulation of body fat: the smoke is clearing

Horváth, T. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19376 · Cited by 79 · see citing works

Disruption of brain stimulation-induced feeding by dopamine receptor blockade

Phillips, A. G., & NIKAIDO, R. S. (1975) · Nature · doi:10.1038/258750a0 · Cited by 78 · see citing works

Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa

Kaye, W. H., Berrettini, W. H., Gwirtsman, H. E., Chrétien, M., Gold, P. W., George, D. T., Jimerson, D. C., & Ebert, M. H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90533-9 · Cited by 78 · see citing works

Pharmacology of Flavor Preference Conditioning in Sham-Feeding Rats

Yu, W.-Z., Sclafani, A. J., Delamater, A. R., & Bodnar, R. J. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00124-0 · Cited by 77 · see citing works

Δ9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus

Corchero, J., Fuentes, J. A., & Manzanares, J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00144-1 · Cited by 72 · see citing works

Naltrexone fails to block the acquisition or expression of a flavor preference conditioned by intragastric carbohydrate infusions

Azzara, A. V., Bodnar, R. J., Delamater, A. R., & Sclafani, A. J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00395-6 · Cited by 71 · see citing works

Facilitory effect of Δ9-tetrahydrocannabinol on hypothalamically induced feeding

Trojniar, W., & Wise, R. A. (1991) · Psychopharmacology · doi:10.1007/bf02244199 · Cited by 67 · see citing works

Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice

Castañé, A., Robledo, P., Matifas, A., Kieffer, B. L., & Maldonado, R. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02409.x · Cited by 67 · see citing works

Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions

Marks-Kaufman, R., Bal'magiya, T. A., & Gross, E. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90016-9 · Cited by 64 · see citing works

CSF beta-endorphin and dynorphin in bulimia nervosa

Brewerton, T. D., Lydiard, R. B., Laraia, M. T., Shook, J. E., & Ballenger, J. C. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1086 · Cited by 63 · see citing works

Obesity Drug Pipeline Not So Fat

Gura, T. (2003) · Science · doi:10.1126/science.299.5608.849 · Cited by 63 · see citing works

Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus

de Yebenes, E. G., Li, S., Fournier, A., St-Pierre, S. A., & Pelletier, G. (1995) · Brain Research · doi:10.1016/0006-8993(94)01429-l · Cited by 62 · see citing works

Opiate antagonists enhance the working memory of rats in the radial maze

Canli, T., Cook, R. G., & Miczek, K. A. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90250-l · Cited by 62 · see citing works

Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice

Chen, R. Z., Huang, R. R., Shen, C.-P., et al. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.004 · Cited by 61 · see citing works

Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of Δ9-tetrahydrocannabinol

Brown, J. E., Kassouny, M. E., & Cross, J. K. (1977) · Behavioral Biology · doi:10.1016/s0091-6773(77)90606-x · Cited by 59 · see citing works

The Effect of Naltrexone on Taste Detection and Recognition Threshold

Arbisi, P. A., Billington, C. J., & Levine, A. S. (1999) · Appetite · doi:10.1006/appe.1998.0217 · Cited by 59 · see citing works

Minireview: Characterization of Influence of Central Nociceptin/Orphanin FQ on Consummatory Behavior

Olszewski, P. K., & Levine, A. S. (2004) · Endocrinology · doi:10.1210/en.2004-0016 · Cited by 59 · see citing works

Pharmacology of Sucrose-Reinforced Place-Preference Conditioning

Delamater, A. R., Sclafani, A. J., & Bodnar, R. J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00251-8 · Cited by 55 · see citing works

Reduced saccharin preference in CXBK (opioid receptor-deficient) mice

Yirmiya, R., Lieblich, I., & Liebeskind, J. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)91360-1 · Cited by 55 · see citing works

Combined Blockade of Both μ- and κ-Opioid Receptors Prevents the Acute Orexigenic Action ofAgouti-Related Protein

Brugman, S., Clegg, D. J., Woods, S. C., & Seeley, R. J. (2002) · Endocrinology · doi:10.1210/en.2002-220230 · Cited by 53 · see citing works

Functional opioid pathways are necessary for hypocretin-1 (orexin-A)-induced feeding

Sweet, D. C., Levine, A. S., & Kotz, C. M. (2004) · Peptides · doi:10.1016/j.peptides.2003.12.014 · Cited by 53 · see citing works

Endogenous opiates and behavior: 2003

Bodnar, R. J., & Klein, G. E. (2004) · Peptides · doi:10.1016/j.peptides.2004.09.005 · Cited by 49 · see citing works

Functional Inactivation of the Nociceptin Receptor by Alanine Substitution of Glutamine 286 at the C Terminus of Transmembrane Segment VI: Evidence from a Site-Directed Mutagenesis Study of the ORL1 Receptor Transmembrane-Binding Domain

Moulédous, L., Topham, C. M., Moisand, C., Mollereau, C., & Meunier, J. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.3.495 · Cited by 49 · see citing works

Bremazocine: A κ‐Opioid Agonist with Potent Analgesic and Other Pharmacologic Properties

Dortch‐Carnes, J., & Potter, D. E. (2005) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00270.x · Cited by 47 · see citing works

Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716

Singh, M. E., Verty, A. N. A., Price, I., McGregor, I. S., & Mallet, P. E. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.008 · Cited by 45 · see citing works

Regional differences in naloxone modulation of Δ9-THC induced Fos expression in rat brain

Allen, K. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00364-7 · Cited by 44 · see citing works

The cannabinoid receptor antagonist SR�141716 attenuates overfeeding induced by systemic or intracranial morphine

Mallet, P. E., Verty, A. N. A., Singh, M. E., & McGregor, I. S. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1451-9 · Cited by 43 · see citing works

The role of the endocannabinoid system in the regulation of energy homeostasis

Cota, D., & Woods, S. C. (2005) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000178715.87999.69 · Cited by 40 · see citing works

Naloxone administration following operant training of sucrose/water discrimination in the rat

O‘Hare, E., Cleary, J. P., Weldon, D. T., Billington, C. J., Levine, A., & Bartz, P. J. (1997) · Psychopharmacology · doi:10.1007/s002130050193 · Cited by 39 · see citing works

Intra-amygdalar injection of DAMGO: effects on c-Fos levels in brain sites associated with feeding behavior

Levine, A. S., Olszewski, P. K., Mullett, M. A., Pomonis, J. D., Grace, M. K., Kotz, C. M., & Billington, C. J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.039 · Cited by 37 · see citing works

Endomorphins and related opioid peptides

Okada, Y., Tsuda, Y., Bryant, S. D., & Lazarust, L. H. (2002) · Vitamins and hormones · doi:10.1016/s0083-6729(02)65067-8 · Cited by 36 · see citing works

Opioid receptor subtype control of galanin-induced feeding

Barton, C., York, D. A., & Bray, G. A. (1996) · Peptides · doi:10.1016/0196-9781(95)02103-5 · Cited by 36 · see citing works

Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614

Zhu, H., Brodsky, M., Gorman, A., & Inturrisi, C. E. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00170-0 · Cited by 33 · see citing works

Naltrexone infusion inhibits the development of preference for a high-sucrose diet

Levine, A. S., Grace, M. K., Cleary, J. P., et al. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00040.2002 · Cited by 32 · see citing works

Effects of Neuropeptide Y on the in vitro Release of Gonadotropin-Releasing Hormone, Luteinizing Hormone, and Beta-Endorphin and Pituitary Responsiveness to Gonadotropin-Releasing Hormone in Female Macaques

Pau, K. ‐. F., Kaynard, A. H., Hess, D. L., et al. (2008) · Neuroendocrinology · doi:10.1159/000125747 · Cited by 27 · see citing works

Polymorphisms of the D2 dopamine receptor gene and alcoholism and other substance use disorders.

Noble, E. (1994) · PubMed · Cited by 26 · see citing works

Analysis of dopamine receptor antagonism upon feeding elicited by mu and delta opioid agonists in the shell region of the nucleus accumbens

Ragnauth, A. K., Znamensky, V., Moroz, M., & Bodnar, R. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02674-3 · Cited by 25 · see citing works

Naltrexone induces arcuate nucleus neuropeptide Y gene expression in the rat

Kotz, C. M., Grace, M. K., Briggs, J. E., et al. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.1.r289 · Cited by 21 · see citing works

The effect of [Phe1ψ(CH2-NH)Gly2]-nociceptin(1-13)NH2 on feeding and c-Fos immunoreactivity in selected brain sites

Olszewski, P. K., Grace, M. K., Billington, C. J., et al. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02603-2 · Cited by 13 · see citing works

Overview of human pharmacokinetics of naltrexone.

Licko, V. (1981) · PubMed · Cited by 9 · see citing works

Effect of rimonabant on weight reduction and cardiovascular risk

Gaal, L. F. V., Rissanen, A., Scheen, A. J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67020-1 · Cited by 9 · see citing works

Effects of intrahypothalamic morphine and its interactions with oxytocin and vasopressin during food intake in rats

Gulati, K., & Ray, A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00502-h · Cited by 8 · see citing works

Stress, eating and the reward system

Adam, T. C., & Epel, E. S. (2007) · Physiology &amp; Behavior · doi:10.1016/j.physbeh.2007.04.011 · Cited by 1,732 · see citing works

Reward, dopamine and the control of food intake: implications for obesity

Volkow, N. D., Wang, G.-J., & Baler, R. D. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.11.001 · Cited by 1,400 · see citing works

Mechanisms of leptin action and leptin resistance.

Myers, M. G., Cowley, M. A., & Münzberg, H. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100707 · Cited by 1,074 · see citing works

The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders

Berridge, K. C., Ho, C.-Y., Richard, J. M., & DiFeliceantonio, A. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.003 · Cited by 873 · see citing works

Obesity and addiction: Neurobiological overlaps

Volkow, N. D., Wang, G. ‐., Tomasi, D., & Baler, R. D. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01031.x · Cited by 800 · see citing works

Acute affective response to a moderate-intensity exercise stimulus predicts physical activity participation 6 and 12 months later

Williams, D. M., Dunsiger, S., Ciccolo, J. T., Lewis, B. A., Albrecht, A. E., & Marcus, B. H. (2008) · Psychology of Sport and Exercise · doi:10.1016/j.psychsport.2007.04.002 · Cited by 633 · see citing works

Food and Drug Reward: Overlapping Circuits in Human Obesity and Addiction

Volkow, N. D., Wang, G. J., Fowler, J. S., Tomasi, D., & Baler, R. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2011_169 · Cited by 525 · see citing works

Exercise, affect, and adherence: an integrated model and a case for self-paced exercise

Williams, D. M. (2008) · Journal of Sport and Exercise Psychology · doi:10.1123/jsep.30.5.471 · Cited by 404 · see citing works

Endocannabinoid Hedonic Hotspot for Sensory Pleasure: Anandamide in Nucleus Accumbens Shell Enhances ‘Liking’ of a Sweet Reward

Mahler, S. V., Smith, K. S., & Berridge, K. C. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301376 · Cited by 377 · see citing works

Dopamine for “Wanting” and Opioids for “Liking”: A Comparison of Obese Adults With and Without Binge Eating

Davis, C. A., Levitan, R. D., Reid, C., Carter, J. C., Kaplan, A. S., Patte, K. A., King, N., Curtis, C., & Kennedy, J. L. (2009) · Obesity · doi:10.1038/oby.2009.52 · Cited by 314 · see citing works

Issues for DSM-V: Should obesity be included as a brain disorder?

Volkow, N. D., & O’Brien, C. P. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.708 · Cited by 271 · see citing works

Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder

Davis, C., Levitan, R. D., Kaplan, A. S., Carter, J., Reid, C., Curtis, C., Patte, K., Hwang, R., & Kennedy, J. L. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.024 · Cited by 200 · see citing works

Anti-obesity therapy: from rainbow pills to polyagonists

Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199 · see citing works

Cannabinoids modulate hippocampal memory and plasticity

Abush, H., & Akirav, I. (2010) · Hippocampus · doi:10.1002/hipo.20711 · Cited by 186 · see citing works

Endocannabinoid signalling: has it got rhythm?

Vaughn, L. K., Denning, G., Stuhr, K. L., de Wit, H., Hill, M. N., & Hillard, C. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00790.x · Cited by 176 · see citing works

Lipids in Psychiatric Disorders and Preventive Medicine

Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175 · see citing works

Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol

Hanlon, E. C., Tasali, E., Leproult, R., Stuhr, K. L., Doncheck, E., de Wit, H., Hillard, C. J., & Van Cauter, E. (2016) · Sleep · doi:10.5665/sleep.5546 · Cited by 150 · see citing works

Latest approaches for the treatment of obesity

Jackson, V. M., Breen, D. M., Fortin, J.-P., Liou, A., Kuzmiski, J. B., Loomis, A. K., Rives, M.-L., Shah, B., & Carpino, P. A. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1044966 · Cited by 132 · see citing works

Abuse victimization in childhood or adolescence and risk of food addiction in adult women

Mason, S. M., Flint, A. J., Field, A. E., Austin, S. B., & Rich‐Edwards, J. W. (2013) · Obesity · doi:10.1002/oby.20500 · Cited by 112 · see citing works

Posttraumatic stress disorder symptoms and food addiction in women by timing and type of trauma exposure

Mason, S. M., Flint, A. J., Roberts, A. L., Agnew-Blais, J., Koenen, K. C., & Rich-Edwards, J. W. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1208 · Cited by 113 · see citing works

Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling

Schneider, P., Bindila, L., Schmahl, C., Bohus, M., Meyer-Lindenberg, A., Lutz, B., Spanagel, R., & Schneider, M. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00203 · Cited by 89 · see citing works

MOSH Syndrome (Male Obesity Secondary Hypogonadism): Clinical Assessment and Possible Therapeutic Approaches

De Lorenzo, A., Noce, A., Moriconi, E., Rampello, T., Marrone, G., Di Daniele, N., & Rovella, V. (2018) · Nutrients · doi:10.3390/nu10040474 · Cited by 68 · see citing works

Learning and the motivation to eat: forebrain circuitry.

Petrovich, G. D. (2011) · Physiology &amp; Behavior · doi:10.1016/j.physbeh.2011.04.059 · Cited by 57 · see citing works

Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent µ-/δ-opioid receptor antagonist, regulates obese-related factors in mice

Marczak, E. D., Jinsmaa, Y., Myers, P. H., Blankenship, T., Wilson, R., Balboni, G., Salvadori, S., & Lazarus, L. H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.041 · Cited by 22 · see citing works

EFFECTS OF CHRONIC EXOGENOUS OPIOID ADMINISTRATION ON LEVELS OF ONE ENDOGENOUS OPIOID (β-ENDORPHIN) IN MAN

Kreek, M. J., Wardlaw, S. L., Friedman, J. M., Schneider, B., & FRANTZ, A. G. (1981) · Elsevier eBooks · doi:10.1016/b978-0-444-80402-0.50123-6 · Cited by 10 · see citing works

Endocannabinoid signaling and food addiction

D’Addario, C., Bonaventura, M. V. M. D., Pucci, M., Romano, A., Gaetani, S., Ciccocioppo, R., Cifani, C., & Maccarrone, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.08.008 · Cited by 123 · see citing works

Sex Differences in Opioid-Mediated Effects: Role of AndrogensPreprint

Sharp, J. L., Pearson, T., & Smith, M. A. (2020) · doi:10.22541/au.160167496.62768848

Regional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain

Zubieta, J.-K., Smith, Y. R., Bueller, J. A., Xu, Y., Kilbourn, M. R., Jewett, D. M., Meyer, C. R., Koeppe, R. A., & Stohler, C. S. (2001) · Science · doi:10.1126/science.1060952 · Cited by 842 · see citing works

Reward processing in obesity, substance addiction and non‐substance addiction

García‐García, I., Horstmann, A., Jurado, M. Á., Garolera, M., Chaudhry, S. J., Margulies, D. S., Villringer, A., & Neumann, J. (2014) · Obesity Reviews · doi:10.1111/obr.12221 · Cited by 180 · see citing works